Citi Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $15
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Cogent Biosciences (COGT) and NeoGenomics (NEO)
Cogent Biosciences Analyst Ratings
A Quick Look at Today's Ratings for Cogent Biosciences(COGT.US), With a Forecast Between $13 to $22
Hold Rating on Cogent Biosciences Amid Competitive Landscape and Anticipated Milestones
JP Morgan Maintains Overweight on Cogent Biosciences, Lowers Price Target to $19
Cogent Biosciences Price Target Maintained With a $18.00/Share by Needham
Cogent Biosciences Analyst Ratings
Cogent Biosciences Garners Buy Rating Amid Promising Clinical Trials and Strategic Growth Potential
LifeSci Capital Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $16
Cogent Biosciences Analyst Ratings
Cogent Biosciences Analyst Ratings
Cogent Biosciences Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardelyx (ARDX), Cogent Biosciences (COGT) and Immunocore Holdings (IMCR)
Piper Sandler Sticks to Their Buy Rating for Cogent Biosciences (COGT)
Neutral Hold Rating on Cogent Biosciences With a $8 Price Target Amidst Clinical and Market Evaluation
Cogent Biosciences Analyst Ratings
Buy Rating on Cogent Biosciences: Financial Stability and Promising Clinical Trials Fuel Positive Outlook
Analyst Issues Buy Rating on Cogent Biosciences Amid Clinical and Financial Milestones
Analysts Offer Insights on Healthcare Companies: Clover Health Investments (CLOV), Cogent Biosciences (COGT) and Adaptive Biotechnologies (ADPT)